Hanoi Medical University, National Hospital of Dermatology and Venereology, Hanoi, Vietnam.
WHO Collaborating Centre for Gonorrhoea and Other Sexually Transmitted Infections, Swedish Reference Laboratory for STIs, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
J Antimicrob Chemother. 2020 Jun 1;75(6):1432-1438. doi: 10.1093/jac/dkaa040.
Antimicrobial resistance (AMR) in Neisseria gonorrhoeae, compromising gonorrhoea treatment, is a threat to reproductive health globally. South-East and East Asia have been major sources of emergence and subsequent international spread of AMR gonococcal strains during recent decades. We investigated gonococcal isolates from 2011 and 2015-16 in Vietnam using AMR testing, WGS and detection of AMR determinants.
Two hundred and twenty-nine gonococcal isolates cultured in 2015-16 (n = 121) and 2011 (n = 108) in Vietnam were examined. AMR testing was performed using Etest and WGS with Illumina MiSeq.
Resistance among the 2015-16 isolates was as follows: ciprofloxacin, 100%; tetracycline, 79%; benzylpenicillin, 50%; cefixime, 15%; ceftriaxone, 1%; spectinomycin, 0%; and 5% were non-WT to azithromycin. Eighteen (15%) isolates were MDR. The MIC range for gentamicin was 2-8 mg/L. Among the 2015-16 isolates, 27% (n = 33) contained a mosaic penA allele, while no isolates had a mosaic penA allele in 2011. Phylogenomic analysis revealed introduction after 2011 of two mosaic penA-containing clones (penA-10.001 and penA-34.001), which were related to cefixime-resistant strains spreading in Japan and Europe, and a minor clade (eight isolates) relatively similar to the XDR strain WHO Q.
From 2011 to 2015-16, resistance in gonococci from Vietnam increased to all currently and previously used antimicrobials except ceftriaxone, spectinomycin and tetracycline. Two mosaic penA-containing clones were introduced after 2011, explaining the increased cefixime resistance. Significantly increased AMR surveillance, antimicrobial stewardship and use of WGS for molecular epidemiology and AMR prediction for gonococcal isolates in Vietnam and other Asian countries are crucial.
淋病奈瑟菌的抗生素耐药性(AMR)威胁着全球的生殖健康,使淋病的治疗变得复杂。在过去几十年中,东南亚和东亚一直是 AMR 淋病菌株出现和随后国际传播的主要来源。我们使用 AMR 检测、WGS 和 AMR 决定因素检测,调查了 2011 年和 2015-16 年越南的淋病分离株。
我们检测了 2015-16 年(n=121)和 2011 年(n=108)在越南培养的 229 株淋病分离株。使用 Etest 和 Illumina MiSeq 的 WGS 进行 AMR 检测。
2015-16 年分离株的耐药情况如下:环丙沙星耐药率 100%;四环素耐药率 79%;青霉素耐药率 50%;头孢克肟耐药率 15%;头孢曲松耐药率 1%;大观霉素耐药率 0%;阿奇霉素非野生型率 5%。18 株(15%)为多药耐药菌。庆大霉素的 MIC 范围为 2-8mg/L。2015-16 年分离株中,27%(n=33)含有镶嵌 penA 等位基因,而 2011 年分离株中没有镶嵌 penA 等位基因。系统发育分析显示,2011 年后引入了两个含有镶嵌 penA 的克隆(penA-10.001 和 penA-34.001),这些克隆与在日本和欧洲传播的头孢克肟耐药菌株有关,还有一个较小的分支(8 株)与 XDR 菌株 WHO Q 较为相似。
从 2011 年到 2015-16 年,越南淋病奈瑟菌对目前和以前使用的所有抗菌药物的耐药性均有所增加,除头孢曲松、大观霉素和四环素外。2011 年后引入了两个含有镶嵌 penA 的克隆,解释了头孢克肟耐药性的增加。在越南和其他亚洲国家,显著增加对抗微生物药物耐药性的监测、抗菌药物管理以及使用 WGS 进行淋病分离株的分子流行病学和 AMR 预测至关重要。